These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 30007292)
1. Can definitive chemoradiotherapy be an alternative to surgery for early-stage oesophageal cancer? Deng HY; Li G; Luo J; Alai G Interact Cardiovasc Thorac Surg; 2019 Jan; 28(1):37-40. PubMed ID: 30007292 [TBL] [Abstract][Full Text] [Related]
2. Does cervical lymph node recurrence after oesophagectomy or definitive chemoradiotherapy for thoracic oesophageal squamous cell carcinoma benefit from salvage treatment? Yuan X; Lv J; Dong H; Wang J Interact Cardiovasc Thorac Surg; 2017 May; 24(5):792-795. PubMed ID: 28453803 [TBL] [Abstract][Full Text] [Related]
3. Prognostic benefit of surgery following chemoradiotherapy for squamous cell carcinoma of the oesophagus. McGlone ER; Khan OA Int J Surg; 2012; 10(7):341-4. PubMed ID: 22641124 [TBL] [Abstract][Full Text] [Related]
4. Does oesophageal stenosis have any impact on survival of oesophageal cancer patients? Deng HY; Li G; Luo J Interact Cardiovasc Thorac Surg; 2018 Sep; 27(3):384-386. PubMed ID: 29617789 [TBL] [Abstract][Full Text] [Related]
5. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer. Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264 [TBL] [Abstract][Full Text] [Related]
6. CROSS and beyond: a clinical perspective on the results of the randomized ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study. van der Woude SO; Hulshof MC; van Laarhoven HW Chin Clin Oncol; 2016 Feb; 5(1):13. PubMed ID: 26932437 [TBL] [Abstract][Full Text] [Related]
7. Does neoadjuvant chemoradiotherapy increase survival in patients with resectable oesophageal cancer? Buderi SI; Shackcloth M; Page RD Interact Cardiovasc Thorac Surg; 2017 Jan; 24(1):115-120. PubMed ID: 27624359 [TBL] [Abstract][Full Text] [Related]
8. Does high body mass index have any impact on survival of patients undergoing oesophagectomy for oesophageal cancer? Deng HY; Qin CL; Qiu XM; Zhou Q Interact Cardiovasc Thorac Surg; 2018 Apr; 26(4):693-695. PubMed ID: 29253176 [TBL] [Abstract][Full Text] [Related]
9. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis. Nomura M; Oze I; Kodaira T; Abe T; Komori A; Narita Y; Masuishi T; Taniguchi H; Kadowaki S; Ura T; Andoh M; Tachibana H; Uemura N; Tajika M; Niwa Y; Muto M; Muro K Int J Clin Oncol; 2016 Oct; 21(5):890-898. PubMed ID: 26980212 [TBL] [Abstract][Full Text] [Related]
10. Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma. Wang BY; Wu SC; Chen HC; Hung WH; Lin CH; Huang CL; Chen HS Br J Surg; 2019 Feb; 106(3):255-262. PubMed ID: 30395362 [TBL] [Abstract][Full Text] [Related]
11. What is the best neoadjuvant regimen prior to oesophagectomy: chemotherapy or chemoradiotherapy? Hamilton E; Vohra RS; Griffiths EA Int J Surg; 2014; 12(3):196-9. PubMed ID: 24361472 [TBL] [Abstract][Full Text] [Related]
12. Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. Jeong Y; Kim JH; Kim SB; Yoon DH; Park SI; Kim YH; Kim HR; Jung HY; Lee GH; Ryu JS J Surg Oncol; 2014 Apr; 109(5):472-7. PubMed ID: 24301552 [TBL] [Abstract][Full Text] [Related]
13. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone. Chen Y; Lu Y; Wang Y; Yang H; Xia Y; Chen M; Song H; Li T; Li D; Wang J; Li S; Wang J Dis Esophagus; 2014; 27(2):134-40. PubMed ID: 23088212 [TBL] [Abstract][Full Text] [Related]
14. Definitive chemoradiation therapy or surgery for clinical T1-3N0-1M0 thoracic esophageal squamous cell carcinoma: A propensity score matching analysis. Li XY; Luo HS; Wu SX; Du ZS; Zheng CP; Wu ZY Asian J Surg; 2019 Jan; 42(1):350-355. PubMed ID: 29802029 [TBL] [Abstract][Full Text] [Related]
15. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Mori M; Doki Y J Surg Oncol; 2009 Nov; 100(6):442-6. PubMed ID: 19653262 [TBL] [Abstract][Full Text] [Related]
16. Cervical Esophageal Cancer Treatment Strategies: A Cohort Study Appraising the Debated Role of Surgery. Valmasoni M; Pierobon ES; Zanchettin G; Briscolini D; Moletta L; Ruol A; Salvador R; Merigliano S Ann Surg Oncol; 2018 Sep; 25(9):2747-2755. PubMed ID: 29987601 [TBL] [Abstract][Full Text] [Related]
17. Radiation field size and dose determine oncologic outcome in esophageal cancer. Gemici C; Yaprak G; Batirel HF; Ilhan M; Mayadagli A World J Surg Oncol; 2016 Oct; 14(1):263. PubMed ID: 27737673 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques. Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166 [TBL] [Abstract][Full Text] [Related]
19. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients. Smit JK; Güler S; Beukema JC; Mul VE; Burgerhof JG; Hospers GA; Plukker JT Ann Surg Oncol; 2013 Nov; 20(12):4008-15. PubMed ID: 23838922 [TBL] [Abstract][Full Text] [Related]
20. Treatment results of radical surgery and definitive chemoradiotherapy for patients with submucosal esophageal squamous cell cancinomas. Toh Y; Ohga T; Itoh S; Kabashima A; Yamamoto K; Adachi E; Sakaguchi Y; Okamura T; Hirata H Anticancer Res; 2006; 26(3B):2487-91. PubMed ID: 16821637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]